Found 0 matching trials
Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation PHASE1 In this study, the investigators test 2 dose levels of thiotepa (5 mg/kg an...
Show More Location
UF Health Shands Children's Hospital
Learn More & Join Trial
Romidepsin Maintenance After Allogeneic Stem Cell Transplantation PHASE1 The goal of this clinical research study is to learn if giving romidepsin b...
Show More Location
The Ohio State University Cancer Center
Learn More & Join Trial
Busulfan (BU) Plus Fludarabine Vs Intravenous BU Plus Cyclophosphamide as Conditioning Regimens Prior Allogeneic Hematopoetic Stem Cells Transplant (HSCT) in AML PHASE3 The purpose of this prospective phase III, open-label, randomized multicent...
Show More Location
Chaim Sheba Medical Center
Learn More & Join Trial
A New Adaptive Feeding Plan for Newborns NA The purpose of this clinical trial is to identify the infant formula(s) for...
Show More Location
Department of Pediatrics
Learn More & Join Trial
Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency PHASE1 The purpose of this study is to evaluate the safety and effectiveness of le...
Show More Location
Laboratory of Host Defenses (LHD), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
Learn More & Join Trial
Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL. PHASE2 RATIONALE: - Relapsed or refractory Neuroblastoma (NBL) carries a very poor...
Show More Location
Children's Memorial Hospital
Learn More & Join Trial
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia NA This pilot clinical trial studies the feasibility of choosing treatment bas...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Itacitinib for the Prevention of Graft Versus Host Disease PHASE2 This phase II trial studies if itacitinib plus standard of care treatment m...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease PHASE1 This is an open-label, single-arm, multicenter, Phase 1/2 study evaluating ...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial